Robin Re of Industry Dive writes, “Since its launch three years ago, InsightCity has been on a mission to take the most important health industry news stories each week, summarize them in context within a weekly newsletter, and makes professionals smarter for the short time invested.
“Now under the stewardship of BioPharma Dive, InsightCity readers will be served with a more in-depth view of the biotech and pharma industries every day. This new chapter marks an exciting milestone and will provide readers with access to more content, reporting, and insights — all while maintaining the same dedication to making them smarter.
“With a community of almost 200,000 active readers, BioPharma Dive is a trusted name in biotech and pharma industry news. With daily insight on everything from gene therapies and biosimilars to big pharma dealmaking and drug pricing, BioPharma Dive provides a unique industry perspective.”
To read more, go here.
Jude Marfil, newsroom operations manager for The Wall Street Journal in its Washington office, was…
Tristan Greene, deputy U.S. news editor at cryptocurrency news site CoinTelegraph, is leaving next month…
Former Business Insider executive editor Rebecca Harrington has been hired by Dynamo to be its…
Bloomberg Television has hired Brenda Kerubo as a desk producer in London. She will be covering Europe's…
In a meeting at CNBC headquarters Thursday afternoon, incoming boss Mark Lazarus presented a bullish…
Ritika Gupta, the BBC's North American business correspondent, was interviewed by Global Woman magazine about…